Concerns about the quality of generic drugs are becoming harder to ignore. On June 25, Valisure Co-Founder David Light joined a MedShadow Foundation webinar to discuss the growing risks of generic medications—and what can be done to improve safety and transparency.
The expert panel included:
Topics covered included:
This event kicked off a new MedShadow webinar series aimed at empowering consumers, clinicians, and policymakers.
As David Light shared during the event, “Independent testing and transparency are critical to ensuring patients get the quality they deserve.”
Missed the webinar? Watch the full recording here.
Concerns about the quality of generic drugs are becoming harder to ignore. On June 25, Valisure Co-Founder David Light joined a MedShadow Foundation webinar to discuss the growing risks of generic medications—and what can be done to improve safety and transparency.
The expert panel included:
Topics covered included:
This event kicked off a new MedShadow webinar series aimed at empowering consumers, clinicians, and policymakers.
As David Light shared during the event, “Independent testing and transparency are critical to ensuring patients get the quality they deserve.”
Missed the webinar? Watch the full recording here.
Concerns about the quality of generic drugs are becoming harder to ignore. On June 25, Valisure Co-Founder David Light joined a MedShadow Foundation webinar to discuss the growing risks of generic medications—and what can be done to improve safety and transparency.
The expert panel included:
Topics covered included:
This event kicked off a new MedShadow webinar series aimed at empowering consumers, clinicians, and policymakers.
As David Light shared during the event, “Independent testing and transparency are critical to ensuring patients get the quality they deserve.”
Missed the webinar? Watch the full recording here.
Concerns about the quality of generic drugs are becoming harder to ignore. On June 25, Valisure Co-Founder David Light joined a MedShadow Foundation webinar to discuss the growing risks of generic medications—and what can be done to improve safety and transparency.
The expert panel included:
Topics covered included:
This event kicked off a new MedShadow webinar series aimed at empowering consumers, clinicians, and policymakers.
As David Light shared during the event, “Independent testing and transparency are critical to ensuring patients get the quality they deserve.”
Missed the webinar? Watch the full recording here.